endpts.com·Jul 1, 2026
In the first half of 2026, forty private biotech companies reported funding rounds of $100 million or more, indicating a rebound in biotech megarounds during this period.
The most valuable insight for you is that there has been a significant rebound in biotech megarounds in the first half of 2026, with 40 private biotech companies each raising $100 million or more. This indicates a robust investment climate in the biotech sector, suggesting potential opportunities for investments or strategic partnerships with these companies.